Navigation Links
Court Grants Preliminary Approval to Class Action Settlement that Provides Benefits Of Approximately $20 Million to Healthcare Providers that Purchased a SS1 Before January 1, 2009
Date:3/4/2011

from STERIS for each Eligible SS1 Device.   In order to receive this settlement consideration, the Court must grant final approval of this settlement and all Class Members (except for those in Sub-Class C) will be required to return their Eligible SS1 Units to STERIS.  Class Members will also be required to return to STERIS all open or used SS1 quick connects, parts, trays, containers, filters, sterility assurance products, S20 sterilant, and other parts, accessories, or consumables for their SS1 Devices that are in the Class Member's possession.  If Class Members have already disposed of these open or used items, they will be given the option to sign a certification confirming that these items have been disposed of and are no longer useable.  

Class members will be mailed a claim form within ten days after the Court grants final approval to the settlement.  The Court will hold a hearing to decide whether to grant final approval to the settlement on June 6, 2011 at 2:00 p.m.  Class members will then have until December 31, 2012 to return their claim form to the address listed on the claim form.  

For additional information about the settlement, you may contact the attorneys below, or visit the settlement website, which will be activated shortly:  http://www.sterilizersettlement.com.  

Attorneys to Contact: Nicholas E. Chimicles (Nick@Chimicles.com) Joseph G. Sauder (JosephSauder@Chimicles.com)Benjamin F. Johns (BFJ@Chimicles.com)361 West Lancaster Avenue, Haverford, PA 19041 Phone: 610-642-8500www.Chimicles.com
'/>"/>

SOURCE Chimicles & Tikellis LLP
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. German High Court Rules in Favor of AmniSure® as New European Guidelines Published
2. US Supreme Court Denies Certiorari and Thereby Leaves in Place Second Circuit Ruling That Novartis Pharmaceuticals Corporation Must Pay its Sales Representatives Overtime Compensation
3. Court of Appeals Overturns $1.8 Billion Patent Verdict for Centocor Ortho Biotech Inc.
4. Final Superior Court Ruling on Trade Secret Lawsuit Favors Volcano Corporation and Its Axsun Subsidiary
5. Watson Announces Favorable District Court Ruling in Generic Mucinex® Patent Suit
6. Massachusetts Court Rules in Favor of Volcano and Against St. Jude Medical Subsidiary in Trade Secrets Case
7. Sensipar® Patents Upheld By District Court
8. U.S. District Court Rules from Bench in Lillys Favor, Confirms Validity of Alimta Patent
9. Occlutech Wins Dutch Appeal Court Ruling Against AGA Medical
10. Mylan to Appeal Court Decision in Generic Paroxetine Hydrochloride CR Case
11. Statement of Ben Anderson, Esq., Regarding Denial of Wyeths En Banc Petition to Sixth Circuit Court of Appeals in Major Drug Regulation Pre-emption Case
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , July 7, 2015   Decision Resources ... differences in dialysis patient management in the U.S. ... submitted by U.S. and EU5 nephrologists from approximately ... binders are the most commonly used renal medications ... iron differs considerably between the two regions.      ...
(Date:7/7/2015)...   InspireMD, Inc. (NYSE MKT: NSPR) ... protection systems ("EPS"), today announced that its MGuard ... MicroNet ™ has received the Frost & ... Award.  Through active market research efforts, Frost & ... the successful introduction of new and innovative products, ...
(Date:7/7/2015)... 2015 Oasmia Pharmaceutical AB, ... within human and veterinary oncology, today announced that ... the United States , designed to ... animal therapeutic.      (Logo: http://photos.prnewswire.com/prnh/20150420/740096) , ... , Paccal Vet-CA1 was previously distributed ...
Breaking Medicine Technology:Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 2Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 3InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 2InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 3InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 4InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 5Oasmia Pharmaceutical Launches US Brand and Sales Platform 2
... April 29, 2011 Centocor Ortho Biotech Products, L.P., ... Drug Application (NDA) for trabectedin for the treatment of ... based on the U.S. Food and Drug Administration,s (FDA) ... to obtain approval. The NDA was submitted ...
... Phil Hagerman, president and CEO of Diplomat Specialty Pharmacy ... of the Year. The award was announced at ... annual award along with Grant Thornton LLP, WWJ Newsradio 950 ... Hagerman was chosen from among 45 nominees profiled during the ...
Cached Medicine Technology:Centocor Ortho Biotech Products, L.P. Voluntarily Withdraws NDA for Trabectedin 2Diplomat Specialty Pharmacy's Hagerman Named Grant Thornton Leader & Innovator of the Year 2Diplomat Specialty Pharmacy's Hagerman Named Grant Thornton Leader & Innovator of the Year 3
(Date:7/7/2015)... Aspen, CO (PRWEB) , ... July 07, 2015 ... ... 726 skin cancer screenings at the Aspen Ideas Festival (AIF), identifying 18 possible ... These potential diagnoses must be confirmed with additional testing. , The Aspen Ideas ...
(Date:7/7/2015)... ... July 07, 2015 , ... A June 29th ... that have emerged about Hillary Clinton. Two plastic surgeons consulted by the publication ... than she has in some time and speculate that she might have benefited ...
(Date:7/7/2015)... ... July 07, 2015 , ... Celestix Networks, ... VE and CelestixFederated VA Series virtual appliances. These virtual platforms expand the ... products, which have proven to simplify the on-premises deployment of unified remote access ...
(Date:7/7/2015)... N.J. (PRWEB) , ... July ... ... CTLT), the leading global provider of advanced delivery technologies and development solutions ... signed an exclusive licensing agreement with Excelimmune, Inc. to access its antibody ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... enhance the experience for its patient community using its IDF ePHR, an electronic ... with primary immunodeficiency diseases (PI) to easily track their health information, including symptoms, ...
Breaking Medicine News(10 mins):Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 2Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 3Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 4Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 2Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 4Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3
... prominent roles in a recent study on the cognitive effects ... and end of one season, 22 percent of those students ... and learning skills than expected, as opposed to only 4 ... shortly after the season and we do not know how ...
... May 17 (HealthDay News) -- Parents of young children with ... bed as their child to monitor their condition, but the ... parents and kids, new research finds. In the study, ... General Hospital for Children in Boston examined the sleeping arrangements ...
... for years that when the proteins RalA and RalB are ... However, until this week, no study had explored the effects ... on the path to developing drugs to target these proteins. ... prostate cancer, to shortened survival in squamous cell carcinoma, a ...
... racial and ethnic disparities in breast cancer exist, they are ... assess the extent of tumors before surgery, according to new ... researchers at the 2012 Annual Meeting of the American Society ... that we didn,t see any differences between black and white ...
... ARBOR, Mich. People with bleeding brain aneurysms have ... they receive aggressive emergency treatment from a specialized team ... patients like them every year, according to new guidelines ... and immediately treating this kind of "bleeding stroke", and ...
... -- A new study confirms the widespread belief that athletes ... may hold clues for managing pain in the general population. ... of more than 550 athletes and more than 330 people ... women, and evaluated pain thresholds (the minimum level of intensity ...
Cached Medicine News:Health News:Parents Often Lose Sleep Over Child's Epilepsy, Study Finds 2Health News:Protein RAL associated with aggressive characteristics in prostate, bladder and skin cancers 2Health News:Fox Chase researchers find no disparities in imaging before breast cancer surgery 2Health News:Specialized care by experienced teams cuts death and disability from bleeding brain aneurysms 2Health News:Specialized care by experienced teams cuts death and disability from bleeding brain aneurysms 3Health News:Athletes Really Do Play Through the Pain 2